Study to Evaluate Effectiveness of Aranesp®
This study has been completed.
Information provided by:
First received: June 30, 2005
Last updated: January 20, 2011
Last verified: January 2011
The purpose of this study was to evaluate subject preference for Aranesp® administered once monthly (i.e., every 4 weeks (Q4W)) or Procrit® administered once weekly (QW).
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Aranesp® Monthly Preference Study|
Resource links provided by NLM:
Further study details as provided by Amgen:
Contacts and Locations